Nissim Greisas

Former Chief Executive Officer at Israel China Biotechnology (ICB) Ltd.

Nissim Greisas

Nissim Greisas

Former Chief Executive Officer at Israel China Biotechnology (ICB) Ltd.

Overview
Career Highlights

Israel China Biotechnology (ICB) Ltd.
Quicare

RelSci Relationships

65

Relationships
RelSci Relationships are individuals Nissim Greisas likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer at BiondVax Pharmaceuticals Ltd.

Relationship likelihood: Average

General LatAm Manager at Allot Ltd.

Relationship likelihood: Average

Head-Software Development at Israel China Biotechnology (ICB) Ltd.

Relationship likelihood: Average

President at Virtual Ports Ltd.

Relationship likelihood: Average

Professor at Tel Aviv University

Relationship likelihood: Average

Former Chief Executive Officer & Vice President-Development at Israel China Biotechnology (ICB) Ltd.

Relationship likelihood: Average

Internal Auditor at Israel China Biotechnology (ICB) Ltd.

Relationship likelihood: Average

Chief Executive Officer at Bsp Co., Inc.

Relationship likelihood: Average

Chief Executive Officer & Director at Israel China Biotechnology (ICB) Ltd.

Relationship likelihood: Average

Director & Vice President-Business Development at Israel China Biotechnology (ICB) Ltd.

Relationship likelihood: Average

Paths to Nissim Greisas
Potential Connections via
Relationship Science
You
Nissim Greisas
Former Chief Executive Officer at Israel China Biotechnology (ICB) Ltd.
Career History
Chief Executive Officer
Prior

Israel China Biotechnology (ICB) Ltd. provides solutions for the diagnosis and monitoring of cardiovascular diseases. The firm is engaged in research, development, production, marketing and sale of technology and products for the diagnosis of ischemic heart disease through the analysis of ECG signals using developed algorithms. It developed HyperQ EX-300 and HyperQ AD-100 systems and the software product HyperQ Analyzer Stress, which allow the diagnosis of cardiac ischemia during the implementation of a standard clinical effort test. The company was founded by Amir Beker on November 15, 1999 and is headquartered in Tel Aviv, Israel.

Chief Executive Officer
Prior
General Manager
Prior
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Nissim Greisas. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Nissim Greisas's profile does not indicate a business or promotional relationship of any kind between RelSci and Nissim Greisas.